Works by Kosiborod, Mikhail

Results: 199
    1

    A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF).

    Published in:
    2019
    By:
    • McMurray, John J.V.;
    • DeMets, David L.;
    • Inzucchi, Silvio E.;
    • Køber, Lars;
    • Kosiborod, Mikhail N.;
    • Langkilde, Anna M.;
    • Martinez, Felipe A.;
    • Bengtsson, Olof;
    • Ponikowski, Piotr;
    • Sabatine, Marc S.;
    • Sjöstrand, Mikaela;
    • Solomon, Scott D.;
    • McMurray, John JV;
    • DeMets, David L;
    • Inzucchi, Silvio E;
    • Kosiborod, Mikhail N;
    • Langkilde, Anna Maria;
    • Martinez, Felipe A;
    • Sabatine, Marc S;
    • Solomon, Scott D
    Publication type:
    journal article
    2

    Change in Urine Albumin-Creatinine Ratio and Occurrence of Hyperkalemia in Patients Initiating Finerenone in the USA: A Cohort Study from the FOUNTAIN Platform.

    Published in:
    Nephron, 2025, v. 149, n. 7, p. 371, doi. 10.1159/000543923
    By:
    • Kovesdy, Csaba P.;
    • Ebert, Natalie;
    • Vizcaya, David;
    • Walsh, Michael;
    • Kosiborod, Mikhail N.;
    • Layton, J. Bradley;
    • Ziemiecki, Ryan;
    • Johannes, Catherine B.;
    • Pladevall-Vila, Manel;
    • Gee, Patrick O.;
    • Jefferson, Nichole;
    • Chicoye, Annie;
    • Lopes, Maria;
    • Thapa, Bishnu Bahadur;
    • Curhan, Gary;
    • Rangel, Luis;
    • Bhartia, Mudit;
    • Liu, Fangfang;
    • Farjat, Alfredo E.;
    • Oberprieler, Nikolaus G.
    Publication type:
    Article
    3
    4

    Lower risk of cardiovascular events and death associated with initiation of sodium‐glucose cotransporter‐2 inhibitors versus sulphonylureas: Analysis from the CVD‐REAL 2 study.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 8, p. 2402, doi. 10.1111/dom.15092
    By:
    • Goh, Su‐Yen;
    • Kosiborod, Mikhail N.;
    • Lam, Carolyn S. P.;
    • Cavender, Matthew A.;
    • Kohsaka, Shun;
    • Norhammar, Anna;
    • Birkeland, Kåre I.;
    • Holl, Reinhard W.;
    • Mauricio, Dídac;
    • Tangri, Navdeep;
    • Shaw, Jonathan E.;
    • Thuresson, Marcus;
    • Fenici, Peter;
    • Kim, Dae Jung
    Publication type:
    Article
    5
    6
    7
    8
    9

    Factors associated with weight loss in people with overweight or obesity living with type 2 diabetes mellitus: Insights from the global DISCOVER study.

    Published in:
    Diabetes, Obesity & Metabolism, 2022, v. 24, n. 9, p. 1734, doi. 10.1111/dom.14745
    By:
    • Hejjaji, Vittal;
    • Gorgojo‐Martinez, Juan J.;
    • Tang, Fengming;
    • Garnelo, Julia Blanco;
    • Cooper, Andrew;
    • Medina, Jesús;
    • Mutiozabal, Miren Sequera;
    • Khunti, Kamlesh;
    • Nicolucci, Antonio;
    • Shestakova, Marina V.;
    • Ji, Linong;
    • Gomes, Marilia B.;
    • Watada, Hirotaka;
    • Vora, Jiten;
    • Malik, Ali O.;
    • Kosiborod, Mikhail;
    • Arnold, Suzanne V.
    Publication type:
    Article
    10

    Prevalence and progression of chronic kidney disease among patients with type 2 diabetes: Insights from the DISCOVER study.

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1956, doi. 10.1111/dom.14401
    By:
    • Khunti, Kamlesh;
    • Charbonnel, Bernard;
    • Chen, Hungta;
    • Cherney, David Z.;
    • Cooper, Andrew;
    • Fenici, Peter;
    • Gomes, Marilia B.;
    • Hammar, Niklas;
    • Heerspink, Hiddo J. L.;
    • Ji, Linong;
    • Medina, Jesús;
    • Nicolucci, Antonio;
    • Ramirez, Larisa;
    • Rathmann, Wolfgang;
    • Shestakova, Marina V.;
    • Shimomura, Iichiro;
    • Tang, Fengming;
    • Watada, Hirotaka;
    • Kosiborod, Mikhail
    Publication type:
    Article
    11

    Association of sodium‐glucose cotransporter‐2 inhibitors with outcomes in type 2 diabetes with reduced and preserved left ventricular ejection fraction: Analysis from the CVD‐REAL 2 study.

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 6, p. 1431, doi. 10.1111/dom.14356
    By:
    • Lam, Carolyn S. P.;
    • Karasik, Avraham;
    • Melzer‐Cohen, Cheli;
    • Cavender, Matthew A.;
    • Kohsaka, Shun;
    • Norhammar, Anna;
    • Thuresson, Marcus;
    • Chen, Hungta;
    • Wittbrodt, Eric;
    • Fenici, Peter;
    • Kosiborod, Mikhail
    Publication type:
    Article
    12

    Dapagliflozin effects on lung fluid volumes in patients with heart failure and reduced ejection fraction: Results from the DEFINE‐HF trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 6, p. 1426, doi. 10.1111/dom.14352
    By:
    • Nassif, Michael E.;
    • Windsor, Sheryl L.;
    • Tang, Fengming;
    • Husain, Mansoor;
    • Inzucchi, Silvio E.;
    • McGuire, Darren K.;
    • Pitt, Bertram;
    • Scirica, Benjamin M.;
    • Austin, Bethany;
    • Fong, Michael W.;
    • LaRue, Shane J.;
    • Umpierrez, Guillermo;
    • Hartupee, Justin;
    • Khariton, Yevgeniy;
    • Malik, Ali O.;
    • Ogunniyi, Modele O.;
    • Wenger, Nanette K.;
    • Kosiborod, Mikhail N.
    Publication type:
    Article
    13

    Effects of dapagliflozin on prevention of major clinical events and recovery in patients with respiratory failure because of COVID‐19: Design and rationale for the DARE‐19 study.

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 4, p. 886, doi. 10.1111/dom.14296
    By:
    • Kosiborod, Mikhail;
    • Berwanger, Otavio;
    • Koch, Gary G.;
    • Martinez, Felipe;
    • Mukhtar, Omar;
    • Verma, Subodh;
    • Chopra, Vijay;
    • Javaheri, Ali;
    • Ambery, Philip;
    • Gasparyan, Samvel B.;
    • Buenconsejo, Joan;
    • Sjöström, C. David;
    • Langkilde, Anna Maria;
    • Oscarsson, Jan;
    • Esterline, Russell
    Publication type:
    Article
    14
    15

    Global patterns of comprehensive cardiovascular risk factor control in patients with type 2 diabetes mellitus: Insights from the DISCOVER study.

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 1, p. 39, doi. 10.1111/dom.14180
    By:
    • Patel, Krishna K.;
    • Gomes, Marilia B.;
    • Charbonnel, Bernard;
    • Chen, Hungta;
    • Cid‐Ruzafa, Javier;
    • Fenici, Peter;
    • Hammar, Niklas;
    • Ji, Linong;
    • Kennedy, Kevin F.;
    • Khunti, Kamlesh;
    • Kosiborod, Mikhail;
    • Pocock, Stuart;
    • Shestakova, Marina V.;
    • Shimomura, Iichiro;
    • Surmont, Filip;
    • Watada, Hirotaka;
    • Arnold, Suzanne V.
    Publication type:
    Article
    16
    17
    18

    Treatment patterns and associated factors in 14 668 people with type 2 diabetes initiating a second‐line therapy: Results from the global DISCOVER study programme.

    Published in:
    Diabetes, Obesity & Metabolism, 2019, v. 21, n. 11, p. 2474, doi. 10.1111/dom.13830
    By:
    • Nicolucci, Antonio;
    • Charbonnel, Bernard;
    • Gomes, Marília B.;
    • Khunti, Kamlesh;
    • Kosiborod, Mikhail;
    • Shestakova, Marina V.;
    • Shimomura, Iichiro;
    • Watada, Hirotaka;
    • Chen, Hungta;
    • Cid‐Ruzafa, Javier;
    • Fenici, Peter;
    • Hammar, Niklas;
    • Surmont, Filip;
    • Tang, Fengming;
    • Pocock, Stuart
    Publication type:
    Article
    19
    20
    21
    22
    23
    24

    Real‐world opportunity of empagliflozin to improve blood pressure control in African American patients with type 2 diabetes: A National Cardiovascular Data Registry "research‐to‐practice" project from the diabetes collaborative registry.

    Published in:
    Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 393, doi. 10.1111/dom.13510
    By:
    • Arnold, Suzanne V.;
    • Seman, Leo;
    • Tang, Fengming;
    • Peri‐okonny, Poghni A.;
    • Ferdinand, Keith C.;
    • Mehta, Sanjeev N.;
    • Goyal, Abhinav;
    • Sperling, Laurence S.;
    • Kosiborod, Mikhail
    Publication type:
    Article
    25
    26

    Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2‐inhibitors versus other glucose‐lowering agents in real‐world clinical practice: Results from the CVD‐REAL study.

    Published in:
    Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 1983, doi. 10.1111/dom.13299
    By:
    • Kosiborod, Mikhail;
    • Birkeland, Kåre I.;
    • Cavender, Matthew A.;
    • Fu, Alex Z.;
    • Wilding, John P.;
    • Khunti, Kamlesh;
    • Holl, Reinhard W.;
    • Norhammar, Anna;
    • Jørgensen, Marit E.;
    • Wittbrodt, Eric T.;
    • Thuresson, Marcus;
    • Bodegård, Johan;
    • Hammar, Niklas;
    • Fenici, Peter;
    • the CVD‐REAL Investigators and Study Group
    Publication type:
    Article
    27
    28
    29
    30
    31

    Patterns of glycaemic control in patients with type 2 diabetes mellitus initiating second‐line therapy after metformin monotherapy: Retrospective data for 10 256 individuals from the United Kingdom and Germany.

    Published in:
    Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 389, doi. 10.1111/dom.13083
    By:
    • Khunti, Kamlesh;
    • Godec, Thomas R.;
    • Medina, Jesús;
    • Garcia‐Alvarez, Laura;
    • Hiller, Josh;
    • Gomes, Marilia B.;
    • Cid‐Ruzafa, Javier;
    • Charbonnel, Bernard;
    • Fenici, Peter;
    • Hammar, Niklas;
    • Hashigami, Kiyoshi;
    • Kosiborod, Mikhail;
    • Nicolucci, Antonio;
    • Shestakova, Marina V.;
    • Ji, Linong;
    • Pocock, Stuart
    Publication type:
    Article
    32

    Real-world use and modeled impact of glucose-lowering therapies evaluated in recent cardiovascular outcomes trials: An NCDR® Research to Practice project.

    Published in:
    European Journal of Preventive Cardiology, 2017, v. 24, n. 15, p. 1637, doi. 10.1177/2047487317729252
    By:
    • Arnold, Suzanne V;
    • Inzucchi, Silvio E;
    • Tang, Fengming;
    • McGuire, Darren K;
    • Mehta, Sanjeev N;
    • Maddox, Thomas M;
    • Goyal, Abhinav;
    • Sperling, Laurence S;
    • Einhorn, Daniel;
    • Wong, Nathan D;
    • Khunti, Kamlesh;
    • Lam, Carolyn SP;
    • Kosiborod, Mikhail
    Publication type:
    Article
    33

    Efficacy and Safety of Dapagliflozin According to Frailty in Heart Failure With Reduced Ejection Fraction : A Post Hoc Analysis of the DAPA-HF Trial.

    Published in:
    2022
    By:
    • Butt, Jawad H;
    • Dewan, Pooja;
    • Merkely, Béla;
    • Belohlávek, Jan;
    • Drożdż, Jarosław;
    • Kitakaze, Masafumi;
    • Inzucchi, Silvio E;
    • Kosiborod, Mikhail N;
    • Martinez, Felipe A;
    • Tereshchenko, Sergey;
    • Ponikowski, Piotr;
    • Bengtsson, Olof;
    • Lindholm, Daniel;
    • Langkilde, Anna Maria;
    • Schou, Morten;
    • Sjöstrand, Mikaela;
    • Solomon, Scott D;
    • Sabatine, Marc S;
    • Chiang, Chern-En;
    • Docherty, Kieran F
    Publication type:
    journal article
    34

    Efficacy and Safety of Dapagliflozin According to Frailty in Heart Failure With Reduced Ejection Fraction: A Post Hoc Analysis of the DAPA-HF Trial.

    Published in:
    Annals of Internal Medicine, 2022, v. 175, n. 6, p. 820, doi. 10.7326/M21-4776
    By:
    • Butt, Jawad H.;
    • Dewan, Pooja;
    • Merkely, Béla;
    • Belohlávek, Jan;
    • Drod, Jarosław;
    • Kitakaze, Masafumi;
    • Inzucchi, Silvio E.;
    • Kosiborod, Mikhail N.;
    • Martinez, Felipe A.;
    • Tereshchenko, Sergey;
    • Ponikowski, Piotr;
    • Bengtsson, Olof;
    • Lindholm, Daniel;
    • Langkilde, Anna Maria;
    • Schou, Morten;
    • Sjöstrand, Mikaela;
    • Solomon, Scott D.;
    • Sabatine, Marc S.;
    • Chiang, Chern-En;
    • Docherty, Kieran F.
    Publication type:
    Article
    35
    36
    37
    38
    39
    40
    41

    Report from the CVOT Summit 2021: new cardiovascular, renal, and glycemic outcomes.

    Published in:
    Cardiovascular Diabetology, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12933-022-01481-0
    By:
    • Schnell, Oliver;
    • Battelino, Tadej;
    • Bergenstal, Richard;
    • Blüher, Matthias;
    • Böhm, Michael;
    • Brosius, Frank;
    • Carr, Richard D.;
    • Ceriello, Antonio;
    • Forst, Thomas;
    • Giorgino, Francesco;
    • Guerci, Bruno;
    • Heerspink, Hiddo J. L.;
    • Itzhak, Baruch;
    • Ji, Linong;
    • Kosiborod, Mikhail;
    • Lalić, Nebojša;
    • Lehrke, Michael;
    • Marx, Nikolaus;
    • Nauck, Michael;
    • Rodbard, Helena W.
    Publication type:
    Article
    42
    43

    Cardiovascular outcomes with sodium–glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data.

    Published in:
    Cardiovascular Diabetology, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12933-021-01345-z
    By:
    • Khunti, Kamlesh;
    • Kosiborod, Mikhail;
    • Kim, Dae Jung;
    • Kohsaka, Shun;
    • Lam, Carolyn S. P.;
    • Goh, Su-Yen;
    • Chiang, Chern-En;
    • Shaw, Jonathan E.;
    • Cavender, Matthew A.;
    • Tangri, Navdeep;
    • Franch-Nadal, Josep;
    • Holl, Reinhard W.;
    • Jørgensen, Marit E.;
    • Norhammar, Anna;
    • Eriksson, Johan G.;
    • Zaccardi, Francesco;
    • Karasik, Avraham;
    • Magliano, Dianna J.;
    • Thuresson, Marcus;
    • Chen, Hungta
    Publication type:
    Article
    44
    45
    46
    47
    48

    Long-term safety and efficacy of sodium zirconium cyclosilicate for hyperkalaemia in patients with mild/moderate versus severe/end-stage chronic kidney disease: comparative results from an open-label, Phase 3 study.

    Published in:
    Nephrology Dialysis Transplantation, 2021, v. 36, n. 1, p. 137, doi. 10.1093/ndt/gfz285
    By:
    • Roger, Simon D;
    • Lavin, Philip T;
    • Lerma, Edgar V;
    • McCullough, Peter A;
    • Butler, Javed;
    • Spinowitz, Bruce S;
    • Haehling, Stephan von;
    • Kosiborod, Mikhail;
    • Zhao, June;
    • Fishbane, Steven;
    • Packham, David K
    Publication type:
    Article
    49
    50

    Continuous glucose control in the ICU: report of a 2013 round table meeting.

    Published in:
    Critical Care, 2014, v. 18, n. 3, p. 226, doi. 10.1186/cc13921
    By:
    • Wernerman, Jan;
    • Desaive, Thomas;
    • Finfer, Simon;
    • Foubert, Luc;
    • Furnary, Anthony;
    • Holzinger, Ulrike;
    • Hovorka, Roman;
    • Joseph, Jeffrey;
    • Kosiborod, Mikhail;
    • Krinsley, James;
    • Mesotten, Dieter;
    • Nasraway, Stanley;
    • Rooyackers, Olav;
    • Schultz, Marcus J.;
    • Van Herpe, Tom;
    • Vigersky, Robert A.;
    • Preiser, Jean-Charles
    Publication type:
    Article